ASY-202

N/A

Report date: 2025/11/13 20:00:06
NME

Base Information

Drug NameASY-202
Drug Alias NameDihydroergotamine Mesylate (Aspeya)ASY202ASY-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAspeya Switzerland SA
China Registration ClassN/A

Develop Information

Active CompaniesAspeya Switzerland SA
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A